CANCELLED - PHASE 1/2, OPEN-LABEL CLINICAL STUDY TO EVALUATE THE SAFETY AND EFFICACY OF INTRATHECAL TSHA101 GENE THERAPY FOR TREATMENT OF INFANTILE ONSET GM2 GANGLIOSIDOSIS

Registry ID

TSHA101-IST-001

Source registry

HEALTH_CANADA

Status

Pending

Phase

PHASE1

Study type

INTERVENTIONAL

Sponsor

QUEENS UNIVERSITY

Last update

2020-12-18

Conditions

• TAY-SACHS DISEASE

View on source registry